China Meheco Xinxing Pharma

China Meheco Xinxing Pharma is a Shanghai-based pharmaceutical manufacturer focused on plasma-derived and related hospital-use products rather than venture-style innovative drug discovery. Publicly available references identify it as a unit affiliated with the state-controlled China Meheco Group and associate it with marketed blood products including human immunoglobulin for intravenous injection and prothrombin complex concentrate. The company appears to operate as a commercial-stage manufacturer and supplier serving the Chinese healthcare market. Available evidence suggests it is a healthcare company, but there is limited transparent public information in English on a proprietary R&D pipeline, molecular targets, or platform technologies. It is best characterized as an established pharma/blood-products manufacturer within the broader China Meheco organization.